Brinker Capital Investments’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Buy
60,089
+27,485
+84% +$147K ﹤0.01% 1642
2026
Q1
$176K Buy
32,604
+18,231
+127% +$109K ﹤0.01% 1883
2025
Q4
$99.9K Buy
+14,373
New +$94.5K ﹤0.01% 2065
2022
Q3
– Sell
-90,974
Closed -$761K – 1328
2022
Q2
$761K Buy
90,974
+1,057
+1% +$14.8K 0.01% 841
2022
Q1
$2.06M Sell
89,917
-9,671
-10% -$236K 0.03% 521
2021
Q4
$2.75M Sell
99,588
-3,861
-4% -$103K 0.04% 452
2021
Q3
$3.03M Hold
103,449
– – 0.05% 411
2021
Q2
$3.03M Buy
103,449
+5,143
+5% +$156K 0.04% 466
2021
Q1
$3.12M Sell
98,306
-92,910
-49% -$2.73M 0.05% 378
2020
Q4
$3.98M Buy
191,216
+104,632
+121% +$1.95M 0.06% 381
2020
Q3
$1.35M Buy
+86,584
New +$1.49M 0.02% 597

Other funds holding BHC

Brinker Capital Investments's BHC Position: Q2 2026 in Review

Brinker Capital Investments increased its Bausch Health (BHC) stake by 84% in Q2 2026, buying an estimated $147K and bringing the position to 60,089 shares worth $296K. The position accounts for ﹤0.01% of the portfolio, ranked #1642.

Brinker Capital Investments first reported a position in BHC in Q3 2020 and has held it in 11 quarters since. The position peaked at $3.98M in Q4 2020. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Brinker Capital Investments held 60,089 shares of Bausch Health worth $296K as of Q2 2026.
  • Brinker Capital Investments bought 27,485 Bausch Health shares in Q2 2026, an estimated $147K.
  • Bausch Health made up ﹤0.01% of Brinker Capital Investments's portfolio in Q2 2026, its #1642 holding.
  • Brinker Capital Investments first reported a position in Bausch Health in Q3 2020 and has held it in 11 quarters since.
  • Brinker Capital Investments's Bausch Health position peaked at $3.98M in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.